
A deal for Merck’s COVID-19 pill to be made and sold cheaply in poor nations has been reached with Medicines Patent Pool, a United Nations-backed nonprofit organization. The royalty-free license means that companies in 105 countries, mostly in Africa and Asia, can sublicense the formulation for the antiviral pill molnupiravir and start making it, the… read on > read on >